近五年，实验室发表学术论文共398篇，其中SCI收录178篇（IF＞4,32篇），中文核心期刊220篇
1.ChenY*, Wang C, ShangH,Yang K, Norris SL. Clinical practice guidelines in China.BMJ. 2018,5;360:j5158.(一区，IF=27.6) 2.ChenYL, Yang KH*, Marusic A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, SchunemannHJ, Chan ESY, Falck-Ytter Y, Ahmed F, Barber S, Chen CF, Zhang MM, Xu B, TianJH, Song FJ, ShangH, TangK, Wang Q, Norris SL*,Practice RRI. A Reporting Tool for Practice Guidelines in Health Care: TheRIGHT Statement. Ann Intern Med. 2017,166(2):128-132.(一区，IF=19.4) 3.ChengCW, Wu TX, ShangH, LiYP, Altman DG, Moher D, Bian ZX*, GrpCF. CONSORT Extension for Chinese Herbal Medicine Formulas 2017:Recommendations, Explanation, and Elaboration. Ann Intern Med. 2017,167(2):112-121.(一区，IF=19.4) 4.YangX, An N, Zhong C, Guan M, Jiang Y, Li X, Zhang H, Wang L, Ruan Y, Gao Y, LiuN*, ShangH*,Xing Y*. Enhanced cardiomyocyte reactive oxygen species signaling promotesibrutinib-induced atrial fibrillation. Redox Biol. 2020;30:101432.(一区，IF=9.9) 5.ZhengHJ # ,Guo J#,Wang QH#,Wang LS, Wang YH, Zhang F, Huang WJ, Zhang WT, Liu WJ*, WangYX*:Probiotics,prebiotics, and synbiotics for the improvement of metabolic profiles in CKDpatients: a systematic review and meta-analysis of randomized controlledtrials.Crit Rev Food Sci Nutr. 1-22.,2020. (一区，IF=7.9) 6.XieJ, Wang H, Kang Y, Zhou L, Liu Z, Qin B, Ma X, Cao X, Chen D, Lu W, Yao C, YuK, Yao X, ShangH, QiuH, Yang Y*; CHinese Epidemiological Study of Sepsis (CHESS) StudyInvestigators. The Epidemiology of Sepsis in Chinese ICUs: A NationalCross-Sectional Survey. Crit Care Med. 2020;48(3):e209-e218.(一区，IF=7.4) 7.SongY, Yao C, Yao Y, Han H, Zhao X, Yu K, Liu L, Xu Y, Liu Z, Zhou Q, Wang Y, Ma Z,Zheng Y, Wu D, Tang Z, Zhang M, Pan S, Chai Y, Song Y, Zhang J, Pan L, Liu Y,Yu H, Yu X, Zhang H, Wang X, Du Z, Wan X, Tang Y, Tian Y, Zhu Y, Wang H, Yan X,Liu Z, Zhang B, Zhong N, ShangH*, BaiC*. XueBiJing Injection Versus Placebo for Critically Ill Patients With SevereCommunity-Acquired Pneumonia: A Randomized Controlled Trial. Crit Care Med,2019. 47(9): p. e735-e743.(一区，IF=6.9) 8.Li Y,Ma J*, Jin Y, Li N, Zheng R, Mu W, Wang J, Si JH, Chen J, ShangH.Benzodiazepines for treatment of patients with delirium excluding those who arecared for in an intensive care unit. Cochrane Database Syst Rev.2020;2(2):CD012670. (IF=7.9) 9.Li X#, LiY#,Zhang T, Xiong X, Liu N, Pang B, Ruan Y, Gao Y, Shang H*,Xing Y*.Role of cardioprotective agents on chemotherapy-induced heart failure: Asystematic review and network meta-analysis of randomized controlled trials.Pharmacol Res. 2020;151:104577.(IF=5.9) 10.LiuWJ, GanY, Huang W F, Wu H L, Zhang X Q, Zheng H J, Liu H F*.Lysosome restoration to activate podocyte autophagy: a new therapeutic strategyfor diabetic kidney disease. Cell Death Dis, 2019. 10(11): p. 806.(IF=5.9) 11.Xu X#,Yang K#,Zhang F#, LiuW, Wang Y, Yu C, Wang J, Zhang K, Zhang C, Nenadic G, Tao D, Zhou X*, ShangH*,Chen J*. Identification of herbal categories active in pain disorder subtypesby machine learning help reveal novel molecular mechanisms of algesia.Pharmacol Res. 2020,156:104797. (IF=5.9) 12.ZhengQ, Yang H, Sun L, Wei RJ, Fu XW, Wang YH, Huang YS, Liu YN*, and LiuWJ*:Efficacyand safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin foranemia in chronic kidney disease patients not undergoing dialysis: A networkmeta-analysis .Pharmacol Res. 159:105020,2020.(IF=5.9) 13.ZhengHJ, Guo J, Jia Q, Huang YS, Huang WJ, Zhang W, Zhang F, LiuWJ*,Wang Y*.The effect of probiotic and synbiotic supplementation on biomarkers ofinflammation and oxidative stress in diabetic patients: A systematic review andmeta-analysis of randomized controlled trials. Pharmacol Res, 2019. 142: p.303-313.(IF=5.6) 14.ShenS, Jiang H, Bei Y, Zhang J, Zhang H, Zhu H, Zhang C, Yao W, Wei C, ShangH*, LiX*.Qiliqiangxin Attenuates Adverse Cardiac Remodeling after MyocardialInfarction in Ovariectomized Mice via Activation of PPARγ. Cell. Physiol.Biochem., 2017,42(3), 876-888. (IF=5.5) 15.ZhangW#, GuH#, LiX, Li Y*,Tang H*,Tian G, ShangH*.(2017).The dark side of "the force" - lipid nanoparticles enhance theoncogenesis of diethylnitrosamine and result in liver cancer in mice.Nanomedicine, 13(2), 701-711. (IF=5.2) 16.Guo J#,Zheng HJ#,Zhang WT, Lou WJ, Xia CH, Han XT, Huang WJ, Zhang F, Wang YX*, and LiuWJ*:Accelerated Kidney Aging in Diabetes Mellitus, Oxid Med Cell Longev.2020.（Accepted，Article ID 1234059）(IF=5.1) 17.Li J,Li Y, Zhang Y, Hu D, GaoY, ShangH*,Xing Y*(2017). The Inhibitory Effect of WenxinKeli on H9C2 CardiomyocytesHypertrophy Induced by Angiotensin II through Regulating Autophagy Activity.Oxid Med Cell Longev, 2017, 7042872. (IF=5.1) 18.SongK, Li Y,Zhang H , An N, WeiY,Wang L,Tian C ,Yuan M, Sun Y, Xing Y*, Gao Y*.Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in NeurologicalDiseases. OxidMed Cell Longev.2020,4356386(IF=5.1) 19.An N#，Gao Y#，Si Z，Zhang H，Wang L，Tian C，Yuan M，Yang X，Li X，ShangH，Xiong X*，Xing Y*.RegulatoryMechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker inCardiovascular Diseases. Front Immunol, 2019. 10: p. 1592.(IF=5.1) 20.YangX，He T，Han S，ZhangX，Sun Y，Xing Y*，Shang H*.TheRole of Traditional Chinese Medicine in the Regulation of Oxidative Stress inTreating Coronary Heart Disease. Oxid Med Cell Longev, 2019. 2019: p.3231424.(IF=5.1） 21.ZhaiJ, Cao H, Ren M, Mu W, Lv S, Si J, Wang H, Chen J*, Shang H*.(2016).Reporting of core items in hierarchical Bayesian analysis for aggregatingN-of-1 trials to estimate population treatment effects is suboptimal. J ClinEpidemiol, 76, 99-107. (IF=4.9) 22.Xu X#,Zhang C#, LiP, Zhang F, Gao K, Chen J*, ShangH*.Drug-symptom networking: Linking drug-likeness screening to drug discovery.Pharmacol Res. 2016,105-113 .(IF=4.5) 23.HuangWJ, LiuWJ, XiaoYH, Zheng HJ, Xiao Y, Jia Q, Jiang HX, Zhu ZB, Xia CH, HanXT, SunRX, Nan H, Feng ZD, Wang SD*, Zhao JX*.Tripterygium andits extracts for diabetic nephropathy: Efficacy and pharmacologicalmechanisms.Biomed Pharmacother. 2020 Jan;121:109599. doi:10.1016/j.biopha.2019.109599. Epub 2019 Nov 7. Review.PMID:31707345(IF=4.5) 24.ZhengHJ, Zhang X, Guo J, Zhang WT, Ai SN, Zhang F, Wang YX*, LiuWJ*:Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease. JCell Mol Med 10.1111/jcmm.15301,2020.(IF=4.5) 25.ZhengQY, Yang HS, Fu XW, Huang YS, Wei RJ, Wang YH, Liu YN*, and LiuWJ*:Theefficacy and safety of roxadustat for anemia in patients with chronic kidneydisease: a meta-analysis. Nephrol Dial Transplant. 2020. （Accepted）(IF=4.5) 26.ZhangP, Du HB, Tong GD, Li XK, Sun XH, Chi XL, Xing YF, Zhou ZH, Li Q, Chen B, WangH, Wang L, Jin H, Mao DW, Wang XB, Wu QK, Li FP, Hu XY, Lu BJ, Yang ZY, ZhangMX, Shi WB, He Q, Li Y, Jiang KP, Xue JD, Li XD, Jiang JM, Lu W, Tian GJ, HuZB, Guo JC, Li CZ, Deng X, Luo XL, Li FY, Zhang XW, Zheng YJ, Zhao G, Wang LC,Wu JH, Guo H, Mi YQ, Gong ZJ, Wang CB, Jiang F, Guo P, Yang XZ, Shi WQ, YangHZ, Zhou Y, Sun NN, Jiao YT, Gao YQ*, Zhou DQ*, Ye YA*.Serum hepatitis B surface antigen correlates with fibrosis andnecroinflammation: A multicentre perspective in China. J Viral Hepat. 2018Sep;25(9):1017-1025. (IF=4.2) 27.WangL, Zhang W, Lu Z, Wang B, Li Y, Yang J, Li P*, Zhao M*(2020) Functional Gene Module–Based Identification of Phillyrin as anAnticardiac Fibrosis Agent. Front. Pharmacol. 11:1077. doi:10.3389/fphar.2020.01077. (IF=4.2) 28.Qiu R,Zhao C, Liang T, Hao X, Huang Y, Zhang X, Chen Z, Wei X, Zhao M, Zhong C, Hu J,Li M, Han S, He T, Sun Y, Chen J, Shang H*.Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chineseand Western Medicine. Front Pharmacol. 2020;11:781.(IF=4.2) 29.ZhangH#,Xing Y#,Chang J#,Wang L, An N, Tian C, Yuan M, Yang X, Shang H, Gao Y*, GaoY*. Efficacy and Safety of NaoShuanTong Capsule in the Treatment of IschemicStroke: A Meta-Analysis. Front Pharmacol, 2019 ,10:1133.(IF=4.2) 30.ZhuZB#,SongK#,HuangWJ#,LiH,Yang H,Bai YQ,Guo KT,Yang RB,Lou WJ,Xia CH, Nie B*, andLiuWJ*:Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function ThroughRegulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in anAtherosclerosis Model. Front Pharmacol. 1:837,2020.(IF=4.2) 31.QinQ, Li X , Li Y,Zhang W, Tian G , Shang H*,Tang H*. AMPK-ERK/CARM1 Signaling Pathways Affect Autophagy of Hepatic Cells inSamples of Liver Cancer Patients. Front Oncol, 2019. 9: p. 1247.(IF=4.1) 32.Li X,ShangH*,Xing Y. New risk stratification on SCN5A mutation in Brugada syndrome. Int JCardiol. 2018, 271:123.(IF=4.0)
|